| Bacterial_endotoxin (#LAL) Testing - #Validation at Minneapolis, Minnesota, USA |
| Email: [email protected] |
|
https://jobs.nvoids.com/job_details.jsp?id=2253732&uid= From: Pavani, KK Software [email protected] Reply to: [email protected] We are hiring #Bacterial_endotoxin (#LAL) Testing - #Validation for one of my client in interesting candidates please send resumes to [email protected] Visa status: : only H1B/GC/USC /GCEAD Position:- :- #Bacterial_endotoxin (#LAL) Testing - #Validation Location: - Minneapolis Downtown, MN JD:- Bacterial endotoxin (#LAL) testing, Total Organic Carbon (#TOC), protein and carbohydrate quantitation, water quality monitoring, Engineering and electrical testing, Installation Qualification, Operational Qualification, Performance Qualification, #Validation Must be proficient in wet chemical methods including measuring, mixing, pipetting, and weighing chemicals, as well as interpreting lab results Microbiological and analytical laboratory tests in the medical or pharma industry preferred Experience working with liquids, solutions, and reagents. Experience in GLP, GDP, and laboratory investigations Utilize standard laboratory equipment The incumbent will follow good practices in recording and reporting data; and have a working understanding of FDA regulations, international standards, and guidance documents applicable to medical devices. Experience with computer record-keeping systems is required Experience with scientific and technical data processing and graphing software is required. Excellent Interpersonal / communication skills, Organizational / planning and Project management skills preferred Personal computer skills, Windows: word processing, presentation, e-mail, web browsers & spreadsheet software Ability to work efficiently, meet timelines, and communicate status (generate trackers, send emails, etc.) Keywords: green card Minnesota Bacterial_endotoxin (#LAL) Testing - #Validation [email protected] https://jobs.nvoids.com/job_details.jsp?id=2253732&uid= |
| [email protected] View All |
| 08:12 PM 13-Mar-25 |